CELL THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
CELL THERAPEUTICS, INC. holds 67 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 41 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CTI, ZEVALIN, and CTI BIOPHARMA. The owner is based in Seattle, WA.
201 Elliott Avenue West, Suite 400
Seattle, WA 98119
Showing of trademarks Trademarks
Trademark Classifications
CELL THERAPEUTICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does CELL THERAPEUTICS, INC. have?
CELL THERAPEUTICS, INC. has 67 U.S. trademarks filed with the USPTO. Of these, 4 registered, 46 abandoned, 17 cancelled.
What trademark classes does CELL THERAPEUTICS, INC. file in?
CELL THERAPEUTICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CELL THERAPEUTICS, INC.'s most well-known trademarks?
CELL THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as CTI, ZEVALIN, and CTI BIOPHARMA. These are among 4 currently registered trademarks in the portfolio.
What is CELL THERAPEUTICS, INC.'s trademark registration success rate?
CELL THERAPEUTICS, INC. has a 6% trademark registration rate, with 4 out of 67 resolved applications resulting in successful registration. Currently, 0 applications are pending review.